| abstract |
The present invention relates to molecules which are immunointeractive with an animal growth factor receptor and, more particularly, to animal neuroepithelial kinase/fetal liver kinase-l receptor (NYK/flk-l). The immunointeractive molecules provide the basis for new therapeutic and diagnostic agents useful in the treatment, prophylaxis and diagnosis of antiogenic-dependent phenotype. |